Figure 1 | Scientific Reports

Figure 1

From: Effective nose-to-brain delivery of exendin-4 via coadministration with cell-penetrating peptides for improving progressive cognitive dysfunction

Figure 1

Schematic diagram of the study conducted to examine the therapeutic potential of nose-to-brain exendin-4 delivery boosted by coadministration with CPP (penetratin) in the mouse model of dementia. Panel A definition of the mild and progressive stages of dementia in SAMP822. Panel B experimental protocols for examining the effects of exendin-4 delivery on progressive cognitive dysfunction.

Back to article page